Published

Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Current topics in behavioral neurosciences
Date: 2022-01-01
Source: PubMed
DOI: 10.1007/7854_2022_365
PubMed: 35546382

Authors

Schindler EAD

Watch author

Derived topics and classifications

psilocybin Chronic Pain Headache / Migraine Review Article Safety Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01 Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09 Safety and Efficacy of Psilocybin for the Treatment of Headache DisordersClinicalTrials.gov · 2023-12-15